Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions.

[1]  P. J. Schlueter,et al.  Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos. , 2005, Molecular endocrinology.

[2]  C. Duan,et al.  Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation* , 2005, Journal of Biological Chemistry.

[3]  S. Kajimura,et al.  Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Bern,et al.  Insulin-like growth factor signaling in fish. , 2005, International review of cytology.

[5]  P. Yin,et al.  Paradoxical Actions of Endogenous and Exogenous Insulin-like Growth Factor-binding Protein-5 Revealed by RNA Interference Analysis* , 2004, Journal of Biological Chemistry.

[6]  P. Yin,et al.  Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells , 2004, Circulation research.

[7]  C. Holding,et al.  Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Duan,et al.  Fibronectin Binds Insulin-like Growth Factor-binding Protein 5 and Abolishes Its Ligand-dependent Action on Cell Migration* , 2004, Journal of Biological Chemistry.

[9]  A. Williams,et al.  IGFBP-3 and apoptosis—a licence to kill? , 2001, Apoptosis.

[10]  D. Accili,et al.  Testis determination requires insulin receptor family function in mice , 2003, Nature.

[11]  F. Tang,et al.  Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1 , 2003 .

[12]  D. Clemmons,et al.  Regulation of Vascular Smooth Muscle Cell Responses to Insulin-like Growth Factor (IGF)-I by Local IGF-binding Proteins* , 2003, Journal of Biological Chemistry.

[13]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[14]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[15]  A. Gunn,et al.  Insulin-like growth factor-1 and post-ischemic brain injury , 2003, Progress in Neurobiology.

[16]  M. Tatar,et al.  The Endocrine Regulation of Aging by Insulin-like Signals , 2003, Science.

[17]  R. Taub,et al.  Impaired Hepatocyte DNA Synthetic Response Posthepatectomy in Insulin-Like Growth Factor Binding Protein 1-Deficient Mice with Defects in C/EBPβ and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Regulation , 2003, Molecular and Cellular Biology.

[18]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[19]  R. Taub,et al.  Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. , 2003, The Journal of clinical investigation.

[20]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.

[21]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[22]  C. McCaig,et al.  Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin , 2002, Journal of Cell Science.

[23]  J. Silha,et al.  Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice , 2002 .

[24]  E. Canalis,et al.  Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. , 2002, Endocrinology.

[25]  C. Duan.  Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. , 2002, The Journal of endocrinology.

[26]  Katherine A. Kelley,et al.  Comparative endocrinology of the insulin-like growth factor-binding protein. , 2002, The Journal of endocrinology.

[27]  L. Wold,et al.  IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. , 2002, American journal of physiology. Endocrinology and metabolism.

[28]  J. Beattie,et al.  Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. , 2002, Development.

[29]  T. Maures,et al.  Structure, developmental expression, and physiological regulation of zebrafish IGF binding protein-1. , 2002, Endocrinology.

[30]  C. McCaig,et al.  Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells. , 2002, Biochemical and biophysical research communications.

[31]  J. Kuemmerle,et al.  Insulin-like Growth Factor-binding Protein-5 (IGFBP-5) Stimulates Growth and IGF-I Secretion in Human Intestinal Smooth Muscle by Ras-dependent Activation of p38 MAP Kinase and Erk1/2 Pathways* , 2002, The Journal of Biological Chemistry.

[32]  E. Ayuso,et al.  β cell expression of IGF-I leads to recovery from type 1 diabetes , 2002 .

[33]  T. Maures,et al.  Structural, biochemical, and expression analysis of two distinct insulin-like growth factor I receptors and their ligands in zebrafish. , 2002, Endocrinology.

[34]  Christophe Héligon,et al.  The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus. , 2002, Developmental biology.

[35]  S. Mohan,et al.  Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)* , 2002, The Journal of Biological Chemistry.

[36]  M. Rechler,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells* , 2002, The Journal of Biological Chemistry.

[37]  R. Baxter,et al.  Signaling through the Smad Pathway by Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells , 2002, The Journal of Biological Chemistry.

[38]  D. Clemmons,et al.  Use of mutagenesis to probe IGF-binding protein structure/function relationships. , 2001, Endocrine reviews.

[39]  E. D. De Robertis,et al.  Neural and head induction by insulin-like growth factor signals. , 2001, Developmental cell.

[40]  G. Shulman,et al.  Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. , 2001, Genes & development.

[41]  P. Lala,et al.  Insulin-Like Growth Factor-Binding Protein 1 Stimulates Human Trophoblast Migration by Signaling through α5β1 Integrin via Mitogen-Activated Protein Kinase Pathway1 , 2001 .

[42]  C. Kenyon.  A Conserved Regulatory System for Aging , 2001, Cell.

[43]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[44]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[45]  S. Mohan,et al.  Evidence that IGF-binding protein-5 functions as a growth factor. , 2001, The Journal of clinical investigation.

[46]  C. McCaig,et al.  Differential insulin‐like growth factor (IGF)‐independent interactions of IGF binding protein‐3 and IGF binding protein‐5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. , 2001, Journal of cellular biochemistry.

[47]  J. Clifford,et al.  Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and Apoptosis* , 2000, The Journal of Biological Chemistry.

[48]  T. Wood,et al.  Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.

[49]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[50]  K. Chihara,et al.  Stimulatory Effect of Insulin‐Like Growth Factor Binding Protein‐5 on Mouse Osteoclast Formation and Osteoclastic Bone‐Resorbing Activity , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  R. Hovorka,et al.  IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. , 2000, Diabetes.

[52]  T. Nam,et al.  Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.

[53]  C. Duan,et al.  Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. , 2000, Circulation research.

[54]  Jun Ding,et al.  Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Mohan,et al.  Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. , 1999, Endocrinology.

[56]  D. Clemmons,et al.  Roles of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathways in Stimulation of Vascular Smooth Muscle Cell Migration and Deoxyriboncleic Acid Synthesis by Insulin-Like Growth Factor-I1. , 1999, Endocrinology.

[57]  L. Bach,et al.  The N-terminal Disulfide Linkages of Human Insulin-like Growth Factor-binding Protein-6 (hIGFBP-6) and hIGFBP-1 Are Different as Determined by Mass Spectrometry* , 1999, The Journal of Biological Chemistry.

[58]  S. S. Huang,et al.  Interactions of High Affinity Insulin-like Growth Factor-binding Proteins with the Type V Transforming Growth Factor-β Receptor in Mink Lung Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[59]  D. Clemmons,et al.  Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. , 1998, Molecular biology of the cell.

[60]  L. Giudice,et al.  Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[62]  D. Clemmons,et al.  Differential Expression and Biological Effects of Insulin-like Growth Factor-binding Protein-4 and -5 in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[63]  D. Andress.  Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. , 1998, American journal of physiology. Endocrinology and metabolism.

[64]  J. Wallace,et al.  Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain* , 1998, The Journal of Biological Chemistry.

[65]  C. Duan.  Nutritional and developmental regulation of insulin-like growth factors in fish. , 1998, The Journal of nutrition.

[66]  C. Duan.  THE INSULIN-LIKE GROWTH FACTOR SYSTEM AND ITS BIOLOGICAL ACTIONS IN FISH , 1997 .

[67]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[68]  C. Abrass,et al.  Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration. , 1997, American journal of physiology. Renal physiology.

[69]  D. Clemmons,et al.  Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. , 1997, The Journal of clinical investigation.

[70]  S. Leal,et al.  The Type V Transforming Growth Factor β Receptor Is the Putative Insulin-like Growth Factor-binding Protein 3 Receptor* , 1997, The Journal of Biological Chemistry.

[71]  T. Nam,et al.  Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. , 1997, Endocrinology.

[72]  R. Rabkin,et al.  Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. , 1997, Endocrinology.

[73]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[74]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[75]  C. Stewart,et al.  Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism , 1996, The Journal of cell biology.

[76]  D. Clemmons,et al.  Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin (*) , 1996, The Journal of Biological Chemistry.

[77]  A. Moses,et al.  Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes , 1996, Diabetes.

[78]  D. Andress.  Heparin Modulates the Binding of Insulin-like Growth Factor (IGF) Binding Protein-5 to a Membrane Protein in Osteoblastic Cells (*) , 1995, The Journal of Biological Chemistry.

[79]  S. Mohan,et al.  Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*) , 1995, The Journal of Biological Chemistry.

[80]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[81]  D. Clemmons,et al.  Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. , 1994, The Journal of biological chemistry.

[82]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[83]  D. Clemmons,et al.  Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[85]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[86]  D. Andress,et al.  Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. , 1993, Biochemical and biophysical research communications.

[87]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[88]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[89]  S. E. Knowles,et al.  Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. , 1992, The Biochemical journal.

[90]  张哉根,et al.  Leu-M , 1991 .

[91]  C. Conover,et al.  Structural and biological characterization of bovine insulin-like growth factor binding protein-3. , 1990, Endocrinology.

[92]  R. Palmiter,et al.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.

[93]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[94]  E. Froesch,et al.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[95]  E. Froesch,et al.  Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. , 1987, The New England journal of medicine.